HCC1937 TNBCSC xenograft chorioallantoic membrane (CAM) model. Bufalin induced G0/G1 phase cell cycle arrest by downregulating key regulatory proteins, including c-myc, cyclin D1, and CDK4. It also promoted intrinsic apoptosis through nuclear fragmentation, mitochondrial membrane potential reduction, and caspase activation. Additionally, bufalin downregulated key CSC markers, such as CD133, CD44, ALDH1A1, Nanog, Oct4, and Sox2. Notably, bufalin suppressed the Wnt/β-catenin signaling pathway by reducing β-catenin mRNA and protein expression, leading to the downregulation of EGFR, a downstream target of Wnt signaling. Our findings highlight bufalin as a potent chemotherapeutic agent capable of inhibiting TNBCSC growth by targeting stemness, proliferation, and apoptosis through Wnt/β-catenin signaling suppression. These results provide a strong rationale for further investigation of bufalin as a potential therapeutic strategy for TNBC treatment.